Epic: A Second Interim Analysis of the Non-Interventional, Observational Multi-Centre Cohort Study of Patients with Chronic Lymphocytic Leukaemia Treated with First-Line Acalabrutinib through the UK Early Access Programme
- Resource Type
- Abstract
- Source
- In
Blood 2 November 2023 142 Supplement 1:6530-6530 - Subject
- Language
- ISSN
- 0006-4971